Aerometrex Upgrades FY26 Earnings Guidance on Record Revenue Growth
Aerometrex Limited (ASX: AMX) has upgraded its preliminary FY26 earnings guidance after delivering record revenue and a sharp improvement in operating performance. The company expects EBITDA to reach between AU$7.5 million and AU$8.0 million, representing growth of 117% to 132% compared to FY25. Estimated group revenue is projected to rise to AU$26.5 million–AU$27.0 million, supported by continued momentum in its MetroMap business. MetroMap subscription revenue is expected to increase by 25.4% to 28.5%, while Annual Contract Value (ACV) has climbed 37.8% to AU$14.55 million.
The company also anticipates a significant turnaround in cash generation, with free cash flow expected to reach AU$4.0 million–AU$4.4 million before lease payments and positive free cash flow after lease payments. Management attributed the improved performance to the strength of the MetroMap subscription model and disciplined cost management, positioning the business for further growth in FY27. The figures remain preliminary and unaudited, with final audited results scheduled for release under the company's standard reporting timetable.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Aerometrex Upgrades FY26 Earnings Guidance on Record Revenue Growth
Aerometrex Limited (ASX: AMX) has upgraded its preliminary FY26 earnings guidance after delivering record revenue and a sharp improvement in operating performance. The company expects EBITDA to reach between AU$7.5 million and AU$8.0 million, representing growth of 117% to 132% compared to FY25. Estimated group revenue is projected to rise to AU$26.5 million–AU$27.0 million, supported by continued momentum in its MetroMap business. MetroMap subscription revenue is expected to increase by 25.4% to 28.5%, while Annual Contract Value (ACV) has climbed 37.8% to AU$14.55 million.
The company also anticipates a significant turnaround in cash generation, with free cash flow expected to reach AU$4.0 million–AU$4.4 million before lease payments and positive free cash flow after lease payments. Management attributed the improved performance to the strength of the MetroMap subscription model and disciplined cost management, positioning the business for further growth in FY27. The figures remain preliminary and unaudited, with final audited results scheduled for release under the company's standard reporting timetable.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au